Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

about

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

Item

http://www.wikidata.org/entity/Q56873610

description

im September 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2014

@uk

name

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@en

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@nl

type

Item

label

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@en

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@nl

prefLabel

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@en

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@nl

P1476

Kardiale Kontraktilitätsmodulation zur Behandlung der symptomatischen Herzinsuffizienz

@en

P2093

J. Kuschyk

http://www.w3.org/2001/XMLSchema#string

M. Borgggrefe

http://www.w3.org/2001/XMLSchema#string

S. Röger

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.

An entirely subcutaneous implantable cardioverter-defibrillator.

A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.

Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.

The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure.

Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure.

Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.

New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.

P2888

s12181-014-0595-7

P304

407-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12181-014-0595-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime